To further define the upstream role of IL-33 and provide rationale for the predominance of more potent, smaller forms of this cytokine in CML mice, we examined proteases that have been shown to cleave IL-33 in vitro43,44. This evidence concerns the gene IL33 and chronic myelogenous leukemia, BCR-ABL1 positive.